aTyr Pharma Inc (LIFE)
1.63
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 10:43
aTyr Pharma Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 3.061M |
| June 30, 2020 | 4.976M |
| March 31, 2020 | 6.866M |
| December 31, 2019 | 8.737M |
| September 30, 2019 | 10.59M |
| June 30, 2019 | 12.42M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
12.42M
Maximum
Jun 2019
2.591M
Average
--
Median
Dec 2020
Total Long Term Debt (Quarterly) Benchmarks
| Vaxart Inc | 0.00 |
| Allogene Therapeutics Inc | 0.00 |
| AIM ImmunoTech Inc | 0.00 |
| Protalix BioTherapeutics Inc | 20.25M |
| Armata Pharmaceuticals Inc | -- |